Camostat is a protease inhibitor used to treat acute pancreatitis and as an antiviral for certain respiratory infections. It works by inhibiting enzymes that break down proteins, thus helping to reduce inflammation in the pancreas. Camostat has been investigated for its potential to inhibit viral entry in the treatment of COVID-19, though more research is needed. Side effects include nausea, abdominal discomfort, and liver enzyme alterations.
Cleanchem is a trusted provider of premium pharmaceutical reference materials, specializing in Camostat and its associated compounds. Our catalog includes pharmacopeial and non-pharmacopeial Camostat impurities, metabolites, nitrosamine derivatives (N-NO compounds), and stable isotope-labeled products. These reference standards play a critical role in pharmaceutical R&D, supporting activities such as product formulation, ANDA and DMF submissions, quality assurance, analytical method development, and stability assessments.
All Camostat-related substances undergo comprehensive characterization and are delivered with complete Certificates of Analysis and supporting analytical documentation to ensure regulatory adherence. Upon request, we can offer EP/USP traceable standards. Our products are routinely re-evaluated to maintain consistent quality and performance.
English
Arabic
Chinese (Simplified)
French
Japanese
Portuguese
Russian
Spanish
